Federal grants to Hbvtech, L.L.C
Hbvtech, L.L.C in Germantown, Maryland received $5.8 million in federal grants from fiscal 2021 to 2025, across 5 awards. Its largest program was Military Medical Research and Development, with $5.3 million. In fiscal 2025 it was awarded $5.0 million.
From USAspending.gov award records, updated October 31, 2026.
- Grants, FY 2021 to 2025$5.8 million
- Awards5
- Awarded in FY 2025$5.0 million
- Largest award$4.7 million
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 2 | $579,854 |
| FY 2022 | 0 | $0 |
| FY 2023 | 1 | $279,993 |
| FY 2024 | 0 | $0 |
| FY 2025 | 2 | $5.0 million |
Programs that fund Hbvtech, L.L.C
| Program | Awards | Amount |
|---|---|---|
| Military Medical Research and Development | 3 | $5.3 million |
| Allergy and Infectious Diseases Research | 2 | $558,750 |
Awarding agencies
| Agency | Awards | Amount |
|---|---|---|
| Department of Defense | 3 | $5.3 million |
| Department of Health and Human Services | 2 | $558,750 |
Largest awards
| Award | Program | First action | Amount |
|---|---|---|---|
| A new hbv cure treatment regimen for durable elimination of hbv cccdna in chronic hb infection | Military Medical Research and Development | June 26, 2025 | $4.7 million |
| A new hbv drug for establishing durable antiviral efficacy of hbv treatment - it is estimated that 292 million people in the world are chronically infected with hepatitis b virus (HBV). Nearly 1 million patients died from hbv related liver diseases each year. Hbv treatment with interferons and nucle | Allergy and Infectious Diseases Research | February 26, 2021 | $300,000 |
| Investigating if cccdna is the first viral dna species to be cleared during hbv clearance | Military Medical Research and Development | February 13, 2023 | $279,993 |
| A novel hbv drug for effective cure of chronic hepatitis b | Military Medical Research and Development | January 15, 2021 | $279,854 |
| A development strategy to obtain ind approval of HBVZ10, a new hbv cure therapy candidate - hbv cccdna persistence is the root cause of chronic hbv infection and cccdna is conventionally viewed as stable in infected cells. Thus, cccdna persistence is currently attributed to the longevity of cccdna m | Allergy and Infectious Diseases Research | August 27, 2025 | $258,750 |
Questions people ask
How much federal grant money does Hbvtech, L.L.C get?
$5.8 million in 5 grant awards from fiscal 2021 to 2025, as obligations reported to USAspending.gov.
Which agency gives Hbvtech, L.L.C the most?
The Department of Defense, with $5.3 million in 3 awards. The Department of Health and Human Services follow.
What is Hbvtech, L.L.C's largest federal grant?
$4.7 million under Military Medical Research and Development, with its first action in the period on June 26, 2025. That counts only the money obligated in fiscal 2021 to 2025.
Which federal programs fund Hbvtech, L.L.C?
Its largest are Military Medical Research and Development and Allergy and Infectious Diseases Research.
Other grant recipients in Germantown
Largest federal grant recipients in Maryland · Federal grants in Maryland